H.R. 4858 (119th)Bill Overview

Ban Harmful Food Dyes Act

Health|Health
Cosponsors
Support
Democratic
Introduced
Aug 1, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill amends the Federal Food, Drug, and Cosmetic Act to declare, beginning January 1, 2027, certain listed color additives unsafe for use in or on food and to deem any food that contains or bears those additives "adulterated." The list includes specific synthetic dyes (Red No. 40, Red No. 3, Yellow No. 5, Yellow No. 6, Blue No. 1, Blue No. 2, Green No. 3, Orange B, Citrus Red 2, Titanium Dioxide) and any additive substantially similar to those listed. Once effective, foods containing these covered color additives would be treated as adulterated under current statutory definitions.

Why people may split

Interpretation of the scientific evidence: liberals see precautionary public-health gains; conservatives see insufficient justification for a categorical ban.

Watch point

Relative to its intended legislative type, this bill clearly accomplishes a direct substantive legal change by amending the FDCA to deem specified color additives unsafe and foods containing them adulterated as of a stated effective date.

This bill amends the Federal Food, Drug, and Cosmetic Act to declare, beginning January 1, 2027, certain listed color additives unsafe for use in or on food and to deem any food that contains or bears those additives "adulterated." The list includes specific synthetic dyes (Red No. 40, Red No. 3, Yellow No. 5, Yellow No. 6, Blue No. 1, Blue No. 2, Green No. 3, Orange B, Citrus Red 2, Titanium Dioxide) and any additive substantially similar to those listed.

Once effective, foods containing these covered color additives would be treated as adulterated under current statutory definitions.

The bill does not, on its face, specify administrative implementation details, exceptions, or transitional assistance beyond the effective date.

Passage30/100

Content alone suggests modest political and legal appeal (public‑health framing, straightforward statutory language), but the bill would impose significant compliance costs on a broad industry, lacks transition funding or carveouts, and removes existing regulatory approvals — factors that historically reduce a bill’s chance of enactment without substantial compromise or compensating provisions. The short, categorical ban and broad 'substantially similar' language increase the likelihood of sustained opposition, amendment pressure, and litigation, lowering overall chances of becoming law.

CredibilityPartially aligned

Relative to its intended legislative type, this bill clearly accomplishes a direct substantive legal change by amending the FDCA to deem specified color additives unsafe and foods containing them adulterated as of a stated effective date. The statutory references and enumerated list of additives provide a concrete legal mechanism, but the text lacks supporting implementation detail, fiscal acknowledgement, handling of edge cases, and accountability provisions.

Contention70/100

Interpretation of the scientific evidence: liberals see precautionary public-health gains; conservatives see insufficient justification for a categorical ban.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Consumers · Federal agenciesSmall businesses

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • ConsumersWould reduce consumer exposure to the listed synthetic color additives, which supporters may argue lowers risks associa…
  • Federal agenciesCreates a clear, uniform federal standard that could simplify regulatory compliance and enforcement by making specified…
  • Potential benefitCould stimulate reformulation and market demand for alternative (e.g., natural or nonlisted) colorants and related R&D…
Likely burdened
  • Small businessesLikely imposes substantial reformulation, sourcing, testing, and relabeling costs on food and beverage manufacturers an…
  • Potential burdenCould disrupt supply chains and reduce product variety (especially in categories such as confectionery, beverages, and…
  • Potential burdenMay generate legal, administrative, and trade disputes over scope and implementation (including litigation over the 'su…
03 · Why people split

Why the argument around this bill splits.

Interpretation of the scientific evidence: liberals see precautionary public-health gains; conservatives see insufficient justification for a categorical ban.
Progressive85%

A mainstream progressive would likely view the bill favorably as a precautionary public-health measure that reduces exposure to synthetic food dyes, especially for children, and as consistent with stronger regulatory oversight.

They would emphasize protections for vulnerable populations and see this as a corrective where prior regulatory approvals were insufficient.

They would want to ensure a just transition for affected workers and small businesses and safe, non-toxic substitutes are available.

Leans supportive
Centrist60%

A moderate would take a cautious but generally sympathetic view: they would welcome stronger consumer protections if backed by solid science and cost-benefit analysis, but worry about economic disruption, unclear implementation, and legal exposure.

They would look for more detail from FDA rulemaking, impact assessments, and a phased approach to reduce unintended consequences.

Overall, they would be open to the bill conditioned on practical safeguards and demonstrated benefits.

Split reaction
Conservative15%

A mainstream conservative would likely oppose the bill or be skeptical, viewing it as federal overreach that imposes regulatory burdens on businesses and raises costs for consumers.

They would question whether the scientific evidence justifies a categorical ban and would be concerned about substitution effects, litigation, and impacts on domestic manufacturers.

They would prefer less prescriptive, market-oriented, or state-led approaches and demand stronger cost-benefit justification and respect for existing FDA processes.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood30/100

Content alone suggests modest political and legal appeal (public‑health framing, straightforward statutory language), but the bill would impose significant compliance costs on a broad industry, lacks transition funding or carveouts, and removes existing regulatory approvals — factors that historically reduce a bill’s chance of enactment without substantial compromise or compensating provisions. The short, categorical ban and broad 'substantially similar' language increase the likelihood of sustained opposition, amendment pressure, and litigation, lowering overall chances of becoming law.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • The bill text contains no legislative cost estimate or analysis of economic impact; unknown scale of reformulation costs to industry and enforcement costs for FDA.
  • No exemptions or transition timelines beyond a single effective date are provided; it is unclear how FDA would implement enforcement, recalls, or permissible thresholds.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Interpretation of the scientific evidence: liberals see precautionary public-health gains; conservatives see insufficient justification for…

Content alone suggests modest political and legal appeal (public‑health framing, straightforward statutory language), but the bill would im…

Unlocked analysis

Relative to its intended legislative type, this bill clearly accomplishes a direct substantive legal change by amending the FDCA to deem specified color additives unsafe and foods containing them adulterated as of a sta…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis